Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Christopher Toepfer


BHF CRE Intermediate Transition Fellow

  • BHF CRE Intermediate Transition Fellow
  • Sir Henry Wellcome Post-Doctoral Fellow
  • Eugene Braunwald Fellowship in Cardiovascular Medicine 2018-2019 BWH

I completed my PhD at Imperial College London and spent my time in Professor Michael Ferenczi and Dr. James Sellers (NHLBI, NIH) laboratories. Studying cardiac muscle regulation in health and disease. Once I finished my PhD I began a Post-doc with the support of a Sir Henry Wellcome Post-Doctoral Fellowship with Professors Christine and Jonathan Seidman at Harvard Medical School and Professor Hugh Watkins at the RDM Oxford.

I have recently been supported by a BHF CRE Intermediate Transition Fellowship In Oxford to investigate the role of thick filament variants in hypertrophic cardiomyopathy (HCM). We perform our research using CRISPR/Cas-9 engineered human induced pluripotent stem cells. These cells can be differentiated into cardiomyocytes, which we use to model human heart disease in a dish. 

Job opening to work on iPSC derived cardiomyocytes:

Recent publications

More publications